Your browser doesn't support javascript.
loading
The 2022 Vaccines Against Shigella and Enterotoxigenic Escherichia coli (VASE) Conference: Summary of breakout workshops.
Baqar, Shahida; Bonavia, Aurelio; Louis Bourgeois, A; Campo, Joseph J; Clifford, Allison; Hanevik, Kurt; Hasso-Agopsowicz, Mateusz; Hausdorff, William; Kaminski, Robert; MacLennan, Calman A; Mantis, Nicholas; Martin, Laura B; Omore, Richard; Pasetti, Marcela; Pavlinac, Patricia; Phalipon, Armelle; Poly, Frédéric; Porter, Chad; Ramasamy, Maheshi N; Rogawski McQuade, Elizabeth T; Sztein, Marcelo B; Walker, Richard.
Affiliation
  • Baqar S; US National Institutes of Health, United States.
  • Bonavia A; Bill & Melinda Gates Medical Research Institute, United States.
  • Louis Bourgeois A; PATH, United States.
  • Campo JJ; Antigen Discovery, Inc, United States.
  • Clifford A; PATH, United States. Electronic address: aclifford@path.org.
  • Hanevik K; University of Bergen, Norway; Norwegian National Advisory Unit for Tropical Infectious Diseases, Medical Department, Haukeland University Hospital, Norway.
  • Hasso-Agopsowicz M; World Health Organization, Switzerland.
  • Hausdorff W; PATH, United States; Faculty of Medicine, Université Libre de Bruxelles, Belgium.
  • Kaminski R; Latham BioPharm Group, United States.
  • MacLennan CA; Enteric and Diarrheal Diseases, Bill & Melinda Gates Foundation, United Kingdom; The Jenner Institute, United Kingdom.
  • Mantis N; Wadsworth Center, New York State Department of Health, United States.
  • Martin LB; US Pharmacopeial Convention, United States.
  • Omore R; Kenya Medical Research Institute Center for Global Health Research, Kenya.
  • Pasetti M; University of Maryland, United States.
  • Pavlinac P; University of Washington, United States.
  • Phalipon A; Institut Pasteur, France.
  • Poly F; Naval Medical Research Command, United States.
  • Porter C; Naval Medical Research Command, United States.
  • Ramasamy MN; Oxford Vaccine Group, University of Oxford, United Kingdom.
  • Rogawski McQuade ET; Emory University, United States.
  • Sztein MB; University of Maryland, United States.
  • Walker R; PATH, United States.
Vaccine ; 42(7): 1445-1453, 2024 Mar 07.
Article in En | MEDLINE | ID: mdl-38036392
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Shigella / Escherichia coli Vaccines / Shigella Vaccines / Escherichia coli Infections / Enterotoxigenic Escherichia coli Limits: Child / Humans Language: En Journal: Vaccine Year: 2024 Document type: Article Affiliation country: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Shigella / Escherichia coli Vaccines / Shigella Vaccines / Escherichia coli Infections / Enterotoxigenic Escherichia coli Limits: Child / Humans Language: En Journal: Vaccine Year: 2024 Document type: Article Affiliation country: Estados Unidos